Breast and Ovarian Cancers: A Survey and Possible Roles for the Cell Surface Heparan Sulfate Proteoglycans

作者: Atsuko Yoneda , Maria E. Lendorf , John R. Couchman , Hinke A. B. Multhaupt

DOI: 10.1369/0022155411428469

关键词:

摘要: Tumor markers are widely used in pathology not only for diagnostic purposes but also to assess the prognosis and predict treatment of tumor. Because tumor marker levels may change over time, it is important get a better understanding molecular changes during progression. Occurrence breast ovarian cancer high older women. Common known risk factors developing these cancers addition age having children or at later age, use hormone replacement therapy, mutations certain genes. In addition, women with history develop cancer. Here, authors review different carcinoma discuss expression, mutations, possible roles cell surface heparan sulfate proteoglycans tumorigenesis carcinomas. The focus on two groups proteoglycans, transmembrane syndecans lipid-anchored glypicans. Both families have been implicated cellular responses growth morphogens, including many now associated

参考文章(164)
Jeffrey S. Ross, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobagyi, Breast Cancer Biomarkers Advances in Clinical Chemistry. ,vol. 40, pp. 99- 125 ,(2005) , 10.1016/S0065-2423(05)40003-7
Ulf Lindahl, Jin‐ping Li, None, Interactions between heparan sulfate and proteins-design and functional implications. International Review of Cell and Molecular Biology. ,vol. 276, pp. 105- 159 ,(2009) , 10.1016/S1937-6448(09)76003-4
D T Bishop, D F Easton, D Ford, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 265- 271 ,(1995)
Jonathan A.C Sterne, David Gavaghan, Matthias Egger, Publication and related bias in meta-analysis : power of statistical tests and prevalence in the literature Journal of Clinical Epidemiology. ,vol. 53, pp. 1119- 1129 ,(2000) , 10.1016/S0895-4356(00)00242-0
SD Raynaud, M Baens, J Grosgeorge, K Rodgers, CD Reid, M Dainton, M Dyer, JG Fuzibet, N Gratecos, B Taillan, N Ayraud, P Marynen, Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood. ,vol. 88, pp. 682- 689 ,(1996) , 10.1182/BLOOD.V88.2.682.BLOODJOURNAL882682
Francisca N'Kuli, Pierre J. Courtoy, G Degeest, I Leenaerts, E Mortier, C Coomans, G. David, Z Zhang, J Schulz, P Zimmermann, Syndecan recycling is controlled by syntenin-PIP2 interaction and Arf6 (vol 9, pg 377, 2005) Developmental Cell. ,vol. 9, pp. 721- 721 ,(2005)
Achilleas D. Theocharis, Spyridon S. Skandalis, George N. Tzanakakis, Nikos K. Karamanos, Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS Journal. ,vol. 277, pp. 3904- 3923 ,(2010) , 10.1111/J.1742-4658.2010.07800.X
Bernard Friedenson, BRCA1 and BRCA2 Pathways and the Risk of Cancers Other Than Breast or Ovarian MedGenMed : Medscape general medicine. ,vol. 7, pp. 60- 60 ,(2005)
Ronald A. DePinho, The age of cancer Nature. ,vol. 408, pp. 248- 254 ,(2000) , 10.1038/35041694
Adi D. Dubash, Marisa M. Menold, Thomas Samson, Etienne Boulter, Rafael García-Mata, Renee Doughman, Keith Burridge, Chapter 1. Focal adhesions: new angles on an old structure. International Review of Cell and Molecular Biology. ,vol. 277, pp. 1- 65 ,(2009) , 10.1016/S1937-6448(09)77001-7